1. Home
  2. NAMI vs FDMT Comparison

NAMI vs FDMT Comparison

Compare NAMI & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMI
  • FDMT
  • Stock Information
  • Founded
  • NAMI 2014
  • FDMT 2013
  • Country
  • NAMI China
  • FDMT United States
  • Employees
  • NAMI N/A
  • FDMT N/A
  • Industry
  • NAMI
  • FDMT Biotechnology: Pharmaceutical Preparations
  • Sector
  • NAMI
  • FDMT Health Care
  • Exchange
  • NAMI NYSE
  • FDMT Nasdaq
  • Market Cap
  • NAMI 208.1M
  • FDMT 268.6M
  • IPO Year
  • NAMI 2024
  • FDMT 2020
  • Fundamental
  • Price
  • NAMI $3.28
  • FDMT $4.64
  • Analyst Decision
  • NAMI
  • FDMT Buy
  • Analyst Count
  • NAMI 0
  • FDMT 10
  • Target Price
  • NAMI N/A
  • FDMT $36.33
  • AVG Volume (30 Days)
  • NAMI 93.3K
  • FDMT 957.1K
  • Earning Date
  • NAMI 03-04-2025
  • FDMT 03-03-2025
  • Dividend Yield
  • NAMI N/A
  • FDMT N/A
  • EPS Growth
  • NAMI N/A
  • FDMT N/A
  • EPS
  • NAMI 0.37
  • FDMT N/A
  • Revenue
  • NAMI $56,127,097.00
  • FDMT $17,000.00
  • Revenue This Year
  • NAMI N/A
  • FDMT N/A
  • Revenue Next Year
  • NAMI N/A
  • FDMT $159.36
  • P/E Ratio
  • NAMI $8.75
  • FDMT N/A
  • Revenue Growth
  • NAMI 64.40
  • FDMT N/A
  • 52 Week Low
  • NAMI $2.26
  • FDMT $4.41
  • 52 Week High
  • NAMI $7.75
  • FDMT $36.25
  • Technical
  • Relative Strength Index (RSI)
  • NAMI N/A
  • FDMT 40.01
  • Support Level
  • NAMI N/A
  • FDMT $4.41
  • Resistance Level
  • NAMI N/A
  • FDMT $5.42
  • Average True Range (ATR)
  • NAMI 0.00
  • FDMT 0.48
  • MACD
  • NAMI 0.00
  • FDMT -0.05
  • Stochastic Oscillator
  • NAMI 0.00
  • FDMT 9.38

About NAMI JINXIN TECHNOLOGY HOLDING COMPANY SPONSORED ADS EACH REP 18 ORD SHS

Jinxin Technology Holding Co is a company which operates through its subsidiaries are principally engaged in provision of digital textbook subscription services in the People's Republic of China. The Company generates revenue by selling its content to hardware manufacturers in China whereby they are allowed to install the Company's digital educational content on the manufacturers' devices for sale to end users.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Share on Social Networks: